We treated human pulmonary alveolar epithelial cells (AECs) with SUMOylation inhibitors, finding that the SUMOylation of ACE2 and infection of pseudotyped SARS-CoV-2 were largely abrogated by SUMOylation inhibitors (Fig. 2d, e). The gene discussed is ACE2; the disease is infection.